Enfortumab vedotin for cisplatin-ineligible urothelial cancer Comment

Pignot, G

Pignot, G (corresponding author), Inst Paoli Calmettes, Dept Surg Oncol 2, F-13009 Marseille, France.

LANCET ONCOLOGY, 2021; 22 (6): 748